 Moncopox is a virus that can cause serious illness and has the potential to spread rapidly. The virus is transmitted through contact with infected animals or their bodily fluids and can be passed between humans via direct contact or indirectly through contaminated objects. The virus is known to replicate in the cytoplasm and requires its own RNA processing machinery, which includes a capping mechanism. Researchers have recently identified a protein called VP39, which is responsible for the capping process. They have also developed a new class of compounds called synefungens, which are able to block the activity of VP39 and prevent the virus from replicating. These compounds have been shown to be effective against other viruses, suggesting they may be useful in treating future outbreaks of Moncopox. This article was authored by Jan Sillon, Martin Klimer, Thomas Otava, and others. We are article.tv, links in the description below.